[1] Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260−272. doi: 10.1016/S0140-6736(13)60687-X [2] Collaboration GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020; 395: 709−733. doi: 10.1016/S0140-6736(20)30045-3 [3] Wang L, Xu X, Zhang M, et al. Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance. JAMA Intern Med 2023; 183: 298−310. doi: 10.1001/jamainternmed.2022.6817 [4] [5] Bielecka-Dabrowa A, von Haehling S, Rysz J, Banach M. Novel drugs for heart rate control in heart failure. Heart Fail Rev 2018; 23: 517−525. doi: 10.1007/s10741-018-9696-x [6] Kercheva M, Ryabov V, Gombozhapova A, et al. Macrophages of the "heart-kidney" axis: their dynamics and correlations with clinical data and outcomes in patients with myocardial infarction. J Pers Med 2022; 12: 127. doi: 10.3390/jpm12020127 [7] Glorieux G, Nigam SK, Vanholder R, Verbeke F. Role of the microbiome in gut-heart-kidney cross talk. Circ Res 2023; 132: 1064−1083. doi: 10.1161/CIRCRESAHA.123.321763 [8] Grassi G, Quarti-Trevano F, Seravalle G, et al. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 2011; 57: 846−851. doi: 10.1161/HYPERTENSIONAHA.110.164780 [9] Böhm M, Reil JC, Danchin N, et al. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH. J Hypertens 2008; 26: 18−25. doi: 10.1097/HJH.0b013e3282f05c8a [10] Peng X, Li Y, Wang X, et al. Relationship between resting heart rate and microalbuminuria in adults with hypertension: national health and nutrition examination survey 2009-2018. Front Cardiovasc Med 2022; 9: 739113. doi: 10.3389/fcvm.2022.739113 [11] Schmieder R, Bramlage P, Haller H, et al. The effect of resting heart rate on the new onset of microalbuminuria in patients with type 2 diabetes: a sub-analysis of the ROADMAP Study. Medicine 2016; 95: e3122. doi: 10.1097/MD.0000000000003122 [12] Chang YK, Fan HC, Lim PS, et al. The relationship between resting heart rate and new-onset microalbuminuria in people with type 2 diabetes: An 8-year follow-up study. Diabet Med 2021; 38: e14436. doi: 10.1111/dme.14436 [13] Miot A, Ragot S, Hammi W, et al. Prognostic value of resting heart rate on cardiovascular and renal outcomes in type 2 diabetic patients: a competing risk analysis in a prospective cohort. Diabetes Care 2012; 35: 2069−2075. doi: 10.2337/dc11-2468 [14] Voors AA, van Veldhuisen DJ, Robertson M, et al. The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT. Eur J Heart Fail 2014; 16: 426−434. doi: 10.1002/ejhf.59 [15] Bohm M, Schumacher H, Schmieder RE, et al. Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies. J Intern Med 2015; 278: 38−49. doi: 10.1111/joim.12333 [16] Inoue T, Iseki K, Iseki C, et al. Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort. Clin Exp Nephrol 2009; 13: 487−493. doi: 10.1007/s10157-009-0193-3 [17]

Mao W, Jin X, Wang H, et al. The Association between Resting Heart Rate and Urinary Albumin/Creatinine Ratio in Middle-Aged and Elderly Chinese Population: A Cross-Sectional Study. J Diabetes Res 2019; 2019: 9718370.

[18] Pfister R, Erdmann E, Schneider CA. Association and prognostic impact of heart rate and micro- albuminuria in patients with type 2 diabetes and cardiovascular disease: results from the PROactive trial. J Atheroscler Thromb 2011; 18: 65−71. doi: 10.5551/jat.6247 [19]

Bartakova V, Klimesova L, Kianickova K, et al. Resting heart rate does not predict cardiovascular and renal outcomes in type 2 diabetic patients. J Diabetes Res 2016; 2016: 6726492.

[20] de Vocht F, Burstyn I, Sanguanchaiyakrit N. Rethinking cumulative exposure in epidemiology, again. J Expo Sci Environ Epidemiol 2015; 25: 467−473. doi: 10.1038/jes.2014.58 [21] Zhao Q, Li H, Wang A, et al. Cumulative resting heart rate exposure and risk of all-cause mortality: results from the Kailuan cohort study. Sci Rep 2017; 7: 40212. doi: 10.1038/srep40212 [22] Yu J, Dai L, Zhao Q, et al. Association of cumulative exposure to resting heart rate with risk of stroke in general population: The Kailuan Cohort Study. J Stroke Cerebrovasc Dis 2017; 26: 2501−2509. doi: 10.1016/j.jstrokecerebrovasdis.2017.05.037 [23] Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 2014; 63: 713−735. doi: 10.1053/j.ajkd.2014.01.416 [24] Navaneethan SD, Zoungas S, Caramori ML, et al. Diabetes management in chronic kidney disease: synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Ann Intern Med 2023; 176: 381−387. doi: 10.7326/M22-2904 [25] Brotman DJ, Bash LD, Qayyum R, et al. Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol 2010; 21: 1560−1570. doi: 10.1681/ASN.2009111112 [26] Wang Y, Yin L, Hu B, et al. Association of heart rate with cardiovascular events and mortality in hypertensive and normotensive population: a nationwide prospective cohort study. Ann Transl Med 2021; 9: 917. doi: 10.21037/atm-21-706 [27]

Converse RL, Jr. Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912−1918.

[28] Custodis F, Baumhakel M, Schlimmer N, et al. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation 2008; 117: 2377−2387. doi: 10.1161/CIRCULATIONAHA.107.746537 [29]

Giannoglou GD, Chatzizisis YS, Zamboulis C, et al. Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol. 2008; 126: 302-312.

[30] Hill GS, Heudes D, Bariéty J. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Kidney Int 2003; 63: 1027−1036. doi: 10.1046/j.1523-1755.2003.00831.x [31] Whelton SP, Narla V, Blaha MJ, et al. Association between resting heart rate and inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin-6, and fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2014; 113: 644−649. doi: 10.1016/j.amjcard.2013.11.009